Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-25 @ 12:49 PM
NCT ID:
NCT00980395
Group ID:
EG000
Title:
VCR (Velcade, Cladribine and Rituximab)
Description:
* Rituximab 375 mg/m2 IV day1
* Cladribine 4 mg/m2 IV over 2 hours days 1-5
* Bortezomib 1.3 mg/m2 IV days 1 and 4
* Repeat every 28 days for a maximum of 6 cycles
rituximab: 375 mg/m2 IV Day 1. Repeat every 28 days for a maximum of 6 cycles.
bortezomib: 1.3 mg/m2 IV Days 1 and 4. Repeat every 28 days for a maximum of 6 cycles.
cladribine: 4 mg/m2 IV over 2 hours Days 1-5. Repeat every 28 days for a maximum of 6 cycles.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
24
Other Number Affected:
24
Other Number At Risk:
24
Study:
NCT00980395
Results Section:
NCT00980395
Adverse Events Module:
NCT00980395